Nifty MidSmall Healthcare News and Updates

Name: Latest research reports of Granules India Ltd. authored by Deven Choksey and published by - Trendlyne research reports.
Item: Granules India Ltd.
Rating: 5
Author: Deven Choksey

Keep track of all breaking news on Nifty MidSmall Healthcare from all sources in a single place.

Poly Medicure Ltd.

29 Aug 2025

2085.40

-0.74%

Stock to buy today: Poly Medicure(2,102.85)

Business Line

From the current level, the stock can appreciate to 2,300 in the near term

Poly Medicure Ltd. is trading below its 100 day SMA of 2220.2

Pfizer Ltd.

28 Aug 2025

5156.00

-0.23%

Why getting Covid-19 vaccine is likely to be more complicated this year?

Business Line

The US Food and Drug Administration has OK'd new shots from Pfizer, Moderna and Novavax, but the approvals came with some new caveats

Pfizer Ltd. has gained 27.31% in the last 6 Months

Aurobindo Pharma Ltd.

26 Aug 2025

1027.90

0.16%

Aurobindo unit gets UK nod for biosimilar breast cancer drug Dazublys

Business Standard

CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, has secured UK MHRA approval for its trastuzumab biosimilar Dazublys, used in HER2-positive breast and gastric cancer treatment

Aurobindo Pharma Ltd. has lost -34.50% in the last 1 Year

Narayana Hrudayalaya Ltd.

25 Aug 2025

1753.80

-0.01%

Key highway projects to boost Mangaluru connectivity by mid-2026

Business Line

While works are underway on various stretches, road widening works on NH-169 will significantly reduce travel time between Mangaluru and tourist centres like Moodbidri and Karkala

Narayana Hrudayalaya Ltd. has gained 38.21% in the last 1 Year

Max Healthcare Institute Ltd.

24 Aug 2025

1154.30

-0.51%

Hospitals To Suspend Cashless Services For Bajaj Allianz Policyholders From Sept. 1

NDTV Profit

This development is crucial as over 15,000 member hospitals including Max Healthcare and Medanta, which would now stop cashless treatment by Bajaj Allianz.

Max Healthcare Insti.. has an average target of 1262.86 from 7 brokers.

Krishna Institute of Medical Sciences Ltd.

23 Aug 2025

723.90

-1.83%

Krishna Institute of Medical Sciences Targets 25-30% Revenue Growth Over Next Four Years

NDTV Profit

KIMS' growing reputation is attracting a higher volume of complex medical cases, which naturally leads to an increase in Average Revenue Per Occupied Bed (ARPOB), according to Dr Bhaskar Rao.

Krishna Institute of Medical Sciences Ltd. is trading above its 200 day SMA of 639.9

Narayana Hrudayalaya Ltd.

22 Aug 2025

1753.80

-0.01%

Narayana Health unveils AIRA by Athma, AI tool for patient data management

Business Standard

Narayana Health's Athma incubator introduces AIRA, an AI-driven tool designed to streamline patient records, enhance efficiency, and reduce errors in healthcare.

Number of FII/FPI investors increased from 277 to 335 in Jun 2025 qtr.

Granules India Ltd.

22 Aug 2025

492.25

5.35%

Can Granules India leverage its strong product pipeline to offset recent profit declines?

Economic Times

Granules India's stock shows a slight recovery despite reporting lower profits in the June quarter. Investors are positive about the company's product pipeline and business stabilisation. The company anticipates better growth in FY27. Approvals for six products in Europe are awaited. Granules focuses on CNS, ADHD, and oncology products. The Gagillapur facility remediation is progressing well with US FDA.

Granules India Ltd. is trading below its 150 day SMA of 495.2

Granules India Ltd.

22 Aug 2025

492.25

5.35%

Modest Q1FY26 growth; facility ramp-up to drive recovery

Buy: Granules India Ltd.

Deven Choksey

We have revised our FY26E/FY27E EPS estimates by -0.6%/-4.6% primarily to reflect a more gradual post-remediation ramp-up at Gagillapur, and a measured margin recovery amid persistent integration and operating costs.